The chart below shows how CRKN performed 10 days before and after its earnings report, based on data from the past quarters. Typically, CRKN sees a +4.24% change in stock price 10 days leading up to the earnings, and a -15.13% change 10 days following the report. On the earnings day itself, the stock moves by -0.21%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Record Revenue Surge: 1. Record Revenue Achievement: Crown Electrokinetics reported record revenues of $8 million for Q3 2024, a significant increase from $0 in the same period of 2023.
Gross Profit Increase: 2. Gross Profit Growth: The company achieved a gross profit of $1.4 million in Q3 2024, compared to $0 in Q3 2023, indicating successful revenue generation from new contracts.
Fiber Optics Pipeline Expansion: 3. Strong Pipeline in Fiber Optics: Crown's Fiber Optics division secured 3 major customer agreements in Q3, contributing to an estimated uncontracted pipeline revenue of over $50 million.
Water Solutions Expansion: 4. Expansion in Water Solutions: The Water Solutions division has over $48 million in anticipated secured projects, with an additional estimated $70 million in expected projects related to lead pipe remediation.
Strong Revenue Projections: 5. Positive Revenue Guidance: Crown anticipates revenue of $9 million for Q4 2024 and projects full-year revenue between $30 million and $35 million for fiscal calendar 2025, indicating strong growth expectations.
Negative
Net Loss Increase: 1. Increased Net Loss: The net loss for Q3 2024 was $5.9 million, up from a net loss of $2.9 million in Q3 2023, indicating a worsening financial position year-over-year.
Increased G&A Expenses: 2. Rising General and Administrative Expenses: G&A expenses rose to $6.5 million in Q3 2024, compared to $2.9 million in the same period of 2023, reflecting a significant increase in operational costs.
Rising Operating Expenses: 3. Higher Operating Expenses: Operating expenses increased to approximately $7.2 million in Q3 2024, up from $3.4 million in Q3 2023, highlighting escalating costs associated with business operations.
Cash Liquidity Issues: 4. Cash Position Concerns: As of September 30, 2024, cash was approximately $3.1 million, raising concerns about the company's liquidity and ability to fund ongoing operations.
R&D Expense Increase: 5. Increased R&D Expenses: R&D expenses grew to $0.7 million in Q3 2024 from $0.5 million in Q3 2023, indicating higher investment in development without immediate returns.
Crown Electrokinetics Corporation (CRKN) Q3 2024 Earnings Call Transcript
CRKN.O
0.02%